Annual SG&A
$477.10 M
-$5.00 M-1.04%
31 December 2023
Summary:
United Therapeutics annual selling, general & administrative expenses is currently $477.10 million, with the most recent change of -$5.00 million (-1.04%) on 31 December 2023. During the last 3 years, it has risen by +$53.20 million (+12.55%). UTHR annual SG&A is now -1.04% below its all-time high of $482.10 million, reached on 31 December 2022.UTHR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$154.10 M
-$23.50 M-13.23%
30 September 2024
Summary:
United Therapeutics quarterly selling, general & administrative expenses is currently $154.10 million, with the most recent change of -$23.50 million (-13.23%) on 30 September 2024. Over the past year, it has increased by +$26.50 million (+20.77%). UTHR quarterly SG&A is now -27.07% below its all-time high of $211.30 million, reached on 31 March 2015.UTHR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$25.89 B
+$1.11 B+4.48%
30 September 2024
Summary:
United Therapeutics TTM selling, general & administrative expenses is currently $25.89 billion, with the most recent change of +$1.11 billion (+4.48%) on 30 September 2024. Over the past year, it has increased by +$25.39 billion (+4996.14%). UTHR TTM SG&A is now at all-time high.UTHR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.0% | +20.8% | +4996.1% |
| 3 y3 years | +12.6% | +41.3% | +5101.6% |
| 5 y5 years | +79.5% | +55.0% | +8247.4% |
UTHR Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.0% | +12.6% | -13.2% | +95.1% | at high | +62.4% |
| 5 y | 5 years | -1.0% | +79.5% | -13.2% | +132.4% | at high | +104.3% |
| alltime | all time | -1.0% | >+9999.0% | -27.1% | +990.8% | at high | +3421.8% |
United Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $154.10 M(-13.2%) | $608.30 M(+4.6%) |
| June 2024 | - | $177.60 M(+23.0%) | $581.80 M(+8.9%) |
| Mar 2024 | - | $144.40 M(+9.2%) | $534.20 M(+12.0%) |
| Dec 2023 | $477.10 M(-1.0%) | $132.20 M(+3.6%) | $477.10 M(-6.1%) |
| Sept 2023 | - | $127.60 M(-1.8%) | $508.10 M(+6.1%) |
| June 2023 | - | $130.00 M(+48.9%) | $478.90 M(-2.3%) |
| Mar 2023 | - | $87.30 M(-46.5%) | $490.40 M(+1.7%) |
| Dec 2022 | $482.10 M(+3.2%) | $163.20 M(+65.9%) | $482.10 M(+7.9%) |
| Sept 2022 | - | $98.40 M(-30.5%) | $446.80 M(-2.3%) |
| June 2022 | - | $141.50 M(+79.1%) | $457.50 M(+6.7%) |
| Mar 2022 | - | $79.00 M(-38.2%) | $428.80 M(-8.2%) |
| Dec 2021 | $467.00 M(+10.2%) | $127.90 M(+17.2%) | $467.00 M(-6.2%) |
| Sept 2021 | - | $109.10 M(-3.3%) | $497.80 M(+9.4%) |
| June 2021 | - | $112.80 M(-3.8%) | $455.00 M(+1.5%) |
| Mar 2021 | - | $117.20 M(-26.1%) | $448.10 M(+5.7%) |
| Dec 2020 | $423.90 M(+26.1%) | $158.70 M(+139.4%) | $423.90 M(+14.4%) |
| Sept 2020 | - | $66.30 M(-37.4%) | $370.40 M(-8.2%) |
| June 2020 | - | $105.90 M(+13.9%) | $403.50 M(+19.7%) |
| Mar 2020 | - | $93.00 M(-11.6%) | $337.20 M(+0.3%) |
| Dec 2019 | $336.20 M(+26.5%) | $105.20 M(+5.8%) | $336.20 M(+8.4%) |
| Sept 2019 | - | $99.40 M(+151.0%) | $310.20 M(-3.3%) |
| June 2019 | - | $39.60 M(-57.0%) | $320.90 M(-11.9%) |
| Mar 2019 | - | $92.00 M(+16.2%) | $364.40 M(+37.1%) |
| Dec 2018 | $265.80 M(-19.5%) | $79.20 M(-28.1%) | $265.80 M(-23.1%) |
| Sept 2018 | - | $110.10 M(+32.5%) | $345.70 M(+22.2%) |
| June 2018 | - | $83.10 M(-1359.1%) | $282.80 M(+5.9%) |
| Mar 2018 | - | -$6.60 M(-104.1%) | $267.10 M(-19.1%) |
| Dec 2017 | $330.10 M(+4.2%) | $159.10 M(+237.1%) | $330.10 M(+6.3%) |
| Sept 2017 | - | $47.20 M(-30.0%) | $310.50 M(-14.6%) |
| June 2017 | - | $67.40 M(+19.5%) | $363.40 M(-1.3%) |
| Mar 2017 | - | $56.40 M(-59.6%) | $368.20 M(+16.2%) |
| Dec 2016 | $316.80 M(-30.0%) | $139.50 M(+39.4%) | $316.80 M(-2.8%) |
| Sept 2016 | - | $100.10 M(+38.6%) | $326.00 M(+56.3%) |
| June 2016 | - | $72.20 M(+1344.0%) | $208.60 M(-15.3%) |
| Mar 2016 | - | $5.00 M(-96.6%) | $246.40 M(-45.6%) |
| Dec 2015 | $452.70 M(+18.7%) | $148.70 M(-959.5%) | $452.70 M(+17.7%) |
| Sept 2015 | - | -$17.30 M(-115.7%) | $384.55 M(-36.4%) |
| June 2015 | - | $110.00 M(-47.9%) | $604.35 M(+7.5%) |
| Mar 2015 | - | $211.30 M(+162.3%) | $562.38 M(+47.5%) |
| Dec 2014 | $381.30 M(-3.2%) | $80.55 M(-60.2%) | $381.30 M(-16.7%) |
| Sept 2014 | - | $202.51 M(+197.7%) | $457.93 M(+31.0%) |
| June 2014 | - | $68.03 M(+125.2%) | $349.54 M(-0.9%) |
| Mar 2014 | - | $30.21 M(-80.8%) | $352.87 M(-10.4%) |
| Dec 2013 | $394.01 M(+95.3%) | $157.18 M(+67.0%) | $394.01 M(+42.3%) |
| Sept 2013 | - | $94.11 M(+31.9%) | $276.90 M(+10.1%) |
| June 2013 | - | $71.36 M(+0.0%) | $251.42 M(+7.8%) |
| Mar 2013 | - | $71.36 M(+78.1%) | $233.31 M(+15.6%) |
| Dec 2012 | $201.75 M(+28.9%) | $40.07 M(-41.6%) | $201.75 M(-8.0%) |
| Sept 2012 | - | $68.63 M(+28.9%) | $219.38 M(+31.0%) |
| June 2012 | - | $53.26 M(+33.9%) | $167.41 M(+21.3%) |
| Mar 2012 | - | $39.79 M(-31.0%) | $138.01 M(-11.8%) |
| Dec 2011 | $156.48 M | $57.71 M(+246.5%) | $156.48 M(-6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $16.66 M(-30.2%) | $166.68 M(-14.8%) |
| June 2011 | - | $23.86 M(-59.1%) | $195.62 M(-2.9%) |
| Mar 2011 | - | $58.26 M(-14.2%) | $201.42 M(+6.0%) |
| Dec 2010 | $188.61 M(+7.0%) | $67.91 M(+48.9%) | $190.03 M(+6.3%) |
| Sept 2010 | - | $45.59 M(+53.7%) | $178.70 M(+2.5%) |
| June 2010 | - | $29.65 M(-36.7%) | $174.28 M(-10.2%) |
| Mar 2010 | - | $46.88 M(-17.1%) | $194.00 M(+10.0%) |
| Dec 2009 | $176.34 M(+87.0%) | $56.58 M(+37.4%) | $176.34 M(+24.5%) |
| Sept 2009 | - | $41.17 M(-16.6%) | $141.63 M(+8.5%) |
| June 2009 | - | $49.37 M(+69.0%) | $130.47 M(+25.2%) |
| Mar 2009 | - | $29.22 M(+33.6%) | $104.19 M(+10.5%) |
| Dec 2008 | $94.31 M(-4.8%) | $21.86 M(-27.2%) | $94.31 M(-19.2%) |
| Sept 2008 | - | $30.02 M(+30.0%) | $116.67 M(+10.3%) |
| June 2008 | - | $23.09 M(+19.5%) | $105.81 M(+2.5%) |
| Mar 2008 | - | $19.33 M(-56.3%) | $103.19 M(+4.2%) |
| Dec 2007 | $99.03 M(+83.3%) | $44.23 M(+130.8%) | $99.03 M(+33.8%) |
| Sept 2007 | - | $19.16 M(-6.4%) | $73.99 M(+9.3%) |
| June 2007 | - | $20.47 M(+35.0%) | $67.72 M(+14.6%) |
| Mar 2007 | - | $15.16 M(-21.0%) | $59.11 M(+9.4%) |
| Dec 2006 | $54.03 M(+119.1%) | $19.19 M(+48.8%) | $54.03 M(+30.2%) |
| Sept 2006 | - | $12.89 M(+8.6%) | $41.51 M(+21.2%) |
| June 2006 | - | $11.87 M(+17.8%) | $34.24 M(+16.5%) |
| Mar 2006 | - | $10.08 M(+51.1%) | $29.39 M(+19.2%) |
| Dec 2005 | $24.66 M(+14.5%) | $6.67 M(+18.7%) | $24.66 M(+4.8%) |
| Sept 2005 | - | $5.62 M(-20.0%) | $23.53 M(+3.5%) |
| June 2005 | - | $7.03 M(+31.6%) | $22.73 M(+7.9%) |
| Mar 2005 | - | $5.34 M(-3.7%) | $21.06 M(-1.7%) |
| Dec 2004 | $21.53 M(-5.0%) | $5.55 M(+15.2%) | $21.42 M(-2.3%) |
| Sept 2004 | - | $4.82 M(-10.1%) | $21.93 M(-3.6%) |
| June 2004 | - | $5.36 M(-6.0%) | $22.74 M(-2.7%) |
| Mar 2004 | - | $5.70 M(-6.0%) | $23.38 M(+3.1%) |
| Dec 2003 | $22.67 M(+42.7%) | $6.06 M(+7.8%) | $22.67 M(+3.6%) |
| Sept 2003 | - | $5.62 M(-6.2%) | $21.89 M(+9.4%) |
| June 2003 | - | $5.99 M(+20.1%) | $20.02 M(+12.6%) |
| Mar 2003 | - | $4.99 M(-5.5%) | $17.78 M(+11.9%) |
| Dec 2002 | $15.89 M(-6.2%) | $5.28 M(+40.9%) | $15.89 M(+9.7%) |
| Sept 2002 | - | $3.75 M(-0.1%) | $14.48 M(-3.9%) |
| June 2002 | - | $3.75 M(+21.1%) | $15.07 M(-1.4%) |
| Mar 2002 | - | $3.10 M(-19.9%) | $15.28 M(-9.8%) |
| Dec 2001 | $16.94 M(+44.4%) | $3.87 M(-10.7%) | $16.94 M(+0.4%) |
| Sept 2001 | - | $4.34 M(+9.4%) | $16.88 M(+12.8%) |
| June 2001 | - | $3.97 M(-16.8%) | $14.97 M(+17.9%) |
| Mar 2001 | - | $4.76 M(+25.0%) | $12.70 M(+8.2%) |
| Dec 2000 | $11.74 M(+134.7%) | $3.81 M(+57.1%) | $11.74 M(+20.7%) |
| Sept 2000 | - | $2.43 M(+43.0%) | $9.72 M(+14.4%) |
| June 2000 | - | $1.70 M(-55.4%) | $8.50 M(+7.5%) |
| Mar 2000 | - | $3.80 M(+111.2%) | $7.90 M(+61.2%) |
| Dec 1999 | $5.00 M(+108.3%) | $1.80 M(+50.0%) | $4.90 M(+58.1%) |
| Sept 1999 | - | $1.20 M(+9.1%) | $3.10 M(+63.2%) |
| June 1999 | - | $1.10 M(+37.5%) | $1.90 M(+137.5%) |
| Mar 1999 | - | $800.00 K | $800.00 K |
| Dec 1998 | $2.40 M | - | - |
FAQ
- What is United Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for United Therapeutics?
- What is United Therapeutics annual SG&A year-on-year change?
- What is United Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for United Therapeutics?
- What is United Therapeutics quarterly SG&A year-on-year change?
- What is United Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for United Therapeutics?
- What is United Therapeutics TTM SG&A year-on-year change?
What is United Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of UTHR is $477.10 M
What is the all time high annual SG&A for United Therapeutics?
United Therapeutics all-time high annual selling, general & administrative expenses is $482.10 M
What is United Therapeutics annual SG&A year-on-year change?
Over the past year, UTHR annual selling, general & administrative expenses has changed by -$5.00 M (-1.04%)
What is United Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of UTHR is $154.10 M
What is the all time high quarterly SG&A for United Therapeutics?
United Therapeutics all-time high quarterly selling, general & administrative expenses is $211.30 M
What is United Therapeutics quarterly SG&A year-on-year change?
Over the past year, UTHR quarterly selling, general & administrative expenses has changed by +$26.50 M (+20.77%)
What is United Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of UTHR is $25.89 B
What is the all time high TTM SG&A for United Therapeutics?
United Therapeutics all-time high TTM selling, general & administrative expenses is $608.30 M
What is United Therapeutics TTM SG&A year-on-year change?
Over the past year, UTHR TTM selling, general & administrative expenses has changed by +$25.39 B (+4996.14%)